Aripiprazole long-acting
Showing 1 - 25 of >10,000
Abilify Maintena + Rexult in Schizophrenia
Recruiting
- Schizophrenia and Related Disorders
- Anxiety Depression
- ARIPiprazole Injection [Abilify]
- Brexpiprazole
-
Hong Kong, Hong KongQueen Mary Hospital
Mar 9, 2022
Breakthrough Symptoms With Long-Acting Injectable Medications
Not yet recruiting
- Schizophrenia
- Schizophrenia Relapse
- Second Generation Long-Acting Injectable Antipsychotic Medications
- (no location specified)
Jul 22, 2022
Schizophrenia Trial in Korea, Republic of (abilify maintena)
Completed
- Schizophrenia
- abilify maintena
-
Busan, Korea, Republic of
- +4 more
Jan 25, 2021
Schizophrenia Trial in Miami (Aripiprazole Lauroxil, Computerized cognitive and functional skills training)
Not yet recruiting
- Schizophrenia
- Aripiprazole Lauroxil
- Computerized cognitive and functional skills training
-
Miami, FloridaJackson Memorial Hospital
Dec 14, 2022
Schizophrenia, Antipsychotics, Long-Acting Injection Trial in Korea, Republic of (Abilify maintena)
Completed
- Schizophrenia
- +4 more
- Abilify maintena
-
Chungju, Chungcheongbuk-do, Korea, Republic of
- +26 more
Dec 16, 2021
Cisgender Female Patients Who Start on Long Acting Cabotegravir
Not yet recruiting
- Hiv
- Cabotegravir Injection [Apretude]
-
Orlando, Florida
- +2 more
Nov 17, 2023
Opioid Use Disorder Trial (naltrexone implant)
Not yet recruiting
- Opioid Use Disorder
- naltrexone implant
- (no location specified)
Dec 7, 2022
Moderate Asthma Trial (Long-Acting Beta Agonist)
Not yet recruiting
- Moderate Asthma
- Long-Acting Beta Agonist
- (no location specified)
Feb 24, 2023
Schizophrenia, Schizoaffective Disorder Trial (LYN-005, Risperidone)
Not yet recruiting
- Schizophrenia
- Schizoaffective Disorder
- (no location specified)
Mar 24, 2023
Implementation and Delivery of Cabotegravir Long Acting
Not yet recruiting
- HIV Infections
- Cabotegravir Injection [Apretude]
-
Seattle, Washington
- +1 more
May 16, 2023
Copd Trial in Assiut (SABA SAMA ICS Vs LABA LAMA ICs)
Not yet recruiting
- Copd
- SABA SAMA ICS Vs LABA LAMA ICs
-
Assiut, EgyptNermen Mohammed Abuelkassem
Feb 28, 2023
Tiotropium + Olodaterol Versus Inhaled Corticosteroids +
Active, not recruiting
- Pulmonary Disease, Chronic Obstructive
- Tiotropium (Tio)
- +4 more
-
Taipei, ChinaNational Tawain University Hospital
Jan 9, 2023
Quality of Life, Clinical Response and Safety of Daily and
Recruiting
- Growth Hormone Deficiency
- Growth Hormone Treatment
- Long-Acting Growth Hormone (LAGH)
-
Minneapolis, MinnesotaUniversity of Minnesota
Sep 29, 2022
HIV-1-infection, HIV, HIV I Infection Trial (CAB + RPV)
Not yet recruiting
- HIV-1-infection
- +2 more
- CAB + RPV
- (no location specified)
Nov 16, 2022
HIV-1-infection Trial in Worldwide (Once daily CAB tablet + RPV tablet, Long acting CAB injectable + long acting RPV injectable)
Not yet recruiting
- HIV-1-infection
- Once daily CAB tablet + RPV tablet
- Long acting CAB injectable + long acting RPV injectable
-
Atlanta, Georgia
- +11 more
Dec 13, 2022
Implantable Long-Acting Pre-Exposure Prophylaxis For MSM
Not yet recruiting
- HIV Prevention
- No intervention
-
Austin, TexasDell Medical School, UT-Austin
Dec 30, 2022
Hiv Trial in United States (Self-guided health education, Patient-provider decision tool, Provider-guided education)
Not yet recruiting
- Hiv
- Self-guided health education
- +2 more
-
Bronx, New York
- +5 more
Apr 17, 2023
Long-acting Injectable Cabotegravir + Rilpivirine
Not yet recruiting
- Patient Satisfaction
- +3 more
-
Santiago, Region Metropolitana, ChileCICUC
Apr 18, 2023
HIV Trial (CAB LA)
Not yet recruiting
- HIV Infections
- CAB LA
- (no location specified)
Nov 21, 2023
Effectiveness and Cost-effectiveness of LADB
Not yet recruiting
- Opioid Dependence
- long-acting depot buprenorphine (LADB)
- (no location specified)
Nov 16, 2023
HIV Trial in Austin (Cabotegravir Formulation F, Cabotegravir Formulation G)
Not yet recruiting
- HIV Infections
- Cabotegravir Formulation F
- Cabotegravir Formulation G
-
Austin, TexasGSK Investigational Site
Sep 4, 2023